logo

Cancer Genetics Inc. (CGIX)



Trade CGIX now with
  Date
  Headline
8/20/2019 8:07:09 AM Cancer Genetics Q2 Net Loss From Cont Ops $0.5 Mln Vs Profit $0.7 Mln Last Year
7/15/2019 4:32:10 PM Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business
1/31/2019 4:03:15 PM Cancer Genetics Announces Closing Of Public Offering Of Common Stock
1/28/2019 10:38:17 PM Cancer Genetics Announces Pricing Of Public Offering Of 15.22 Mln Shares At $0.23/shr
1/28/2019 4:00:55 PM Cancer Genetics Announces Proposed Public Offering Of Common Stock
1/9/2019 11:21:45 PM Cancer Genetics Announces Pricing Of Public Offering Of 13.33 Mln Shares At $0.225/Shr
1/9/2019 8:13:41 AM Cancer Genetics Appoints William Finger As EVP, Precision Medicine And Biopharma Solutions
12/17/2018 8:14:14 AM Cancer Genetics Terminates Merger Agreement With NovellusDx
11/14/2018 4:12:31 PM Cancer Genetics Appoints Glenn Miles As CFO
10/18/2018 9:08:18 AM Cancer Genetics Signs Exclusive Distribution Agreement With Genecast Biotechnology
10/8/2018 7:05:10 AM Cancer Genetics And Cellaria Partner On Precision Medicine Tools
9/25/2018 4:14:31 PM Cancer Genetics Enters Supply Agreement With Agilent Technologies
9/18/2018 8:31:58 AM NovellusDx To Merge With Newly Formed Israeli Subsidiary Of Cancer Genetics
8/14/2018 7:34:07 AM Cancer Genetics Q2 Net Loss $3.6 Mln Or $0.13/shr Vs Loss $2.8 Mln Or $0.16/Shr Last Year
6/12/2018 8:04:55 AM Cancer Genetics Strengthens Management Team With Appointment Of Michael McCartney As Chief Commercial Officer